3P Clinical significance of achieving no evidence of disease in HER2-positive metastatic breast cancer: A multicenter study by Turkish Oncology Group (TOG)

Achieving no evidence of disease (NED) in HER2-positive metastatic breast cancer (MBC) has been proposed as a surrogate for durable disease control. However, its clinical significance and predictive factors are not yet well established.